DRD2, DRD3, and HTR2A Single-Nucleotide Polymorphisms Involvement in High Treatment Resistance to Atypical Antipsychotic Drugs

DRD2, DRD3, and HTR2A Single-Nucleotide Polymorphisms Involvement in High Treatment Resistance to Atypical Antipsychotic Drugs

Background: The objective of this study was to investigate the <i>DRD2</i> rs1800497, rs1799732, rs1801028, <i>DRD3</i> rs6280, and <i>HTR2A</i> rs6314, rs7997012, and rs6311 single-nucleotide polymorphism (SNP) correlations with resistance to second-generation an...

Full description

Bibliographic Details
Main Authors: Antonio Del Casale, Maurizio Simmaco, Martina Nicole Modesti, Clarissa Zocchi, Jan Francesco Arena, Irene Bilotta, Alessandro Alcibiade, Giuseppe Sarli, Lorenzo Cutillo, Giulia Antonelli, Enrico La Spina, Ottavia De Luca, Robert Preissner, Marina Borro, Giovanna Gentile, Paolo Girardi, Maurizio Pompili
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Biomedicines
Subjects:
antipsychotic agents
dopamine receptors
5-hydroxytryptamine receptors
drug resistance
pharmacogenomic variants
precision medicine
Online Access:https://www.mdpi.com/2227-9059/11/7/2088

Internet

https://www.mdpi.com/2227-9059/11/7/2088

Similar Items